CollPlant Biotechnologies Ltd Cash Equivalents, at Carrying Value
CollPlant Biotechnologies Ltd (CLGN) had Cash Equivalents, at Carrying Value of $5.59 million as of 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-03-26
- 2025-12-31: Cash Equivalents, at Carrying Value $5.59M.
- 2025-06-30: Cash Equivalents, at Carrying Value $11.43M.
- 2024-12-31: Cash Equivalents, at Carrying Value $11.91M.
- 2024-06-30: Cash Equivalents, at Carrying Value $18.92M.
| Period end | Cash Equivalents, at Carrying Value |
|---|---|
| 2025-12-31 | $5.59M 20-F · filed 2026-03-26 |
| 2025-06-30 | $11.43M 6-K · filed 2025-08-20 |
| 2024-12-31 | $11.91M 20-F · filed 2025-03-26 |
| 2024-06-30 | $18.92M 6-K · filed 2024-08-20 |
| 2023-12-31 | $26.67M 20-F · filed 2024-04-04 |